WRN exonuclease imparts high fidelity on translesion synthesis by Y family DNA polymerases

xs© 2024 Yoon et al.; Published by Cold Spring Harbor Laboratory Press..

Purified translesion synthesis (TLS) DNA polymerases (Pols) replicate through DNA lesions with a low fidelity; however, TLS operates in a predominantly error-free manner in normal human cells. To explain this incongruity, here we determine whether Y family Pols, which play an eminent role in replication through a diversity of DNA lesions, are incorporated into a multiprotein ensemble and whether the intrinsically high error rate of the TLS Pol is ameliorated by the components in the ensemble. To this end, we provide evidence for an indispensable role of Werner syndrome protein (WRN) and WRN-interacting protein 1 (WRNIP1) in Rev1-dependent TLS by Y family Polη, Polι, or Polκ and show that WRN, WRNIP1, and Rev1 assemble together with Y family Pols in response to DNA damage. Importantly, we identify a crucial role of WRN's 3' → 5' exonuclease activity in imparting high fidelity on TLS by Y family Pols in human cells, as the Y family Pols that accomplish TLS in an error-free manner manifest high mutagenicity in the absence of WRN's exonuclease function. Thus, by enforcing high fidelity on TLS Pols, TLS mechanisms have been adapted to safeguard against genome instability and tumorigenesis.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Genes & development - 38(2024), 5-6 vom: 17. Apr., Seite 213-232

Sprache:

Englisch

Beteiligte Personen:

Yoon, Jung-Hoon [VerfasserIn]
Sellamuthu, Karthi [VerfasserIn]
Prakash, Louise [VerfasserIn]
Prakash, Satya [VerfasserIn]

Links:

Volltext

Themen:

DNA lesions
DNA repair
DNA-Directed DNA Polymerase
EC 2.7.7.7
EC 3.1.-
EC 3.6.4.12
Exonucleases
Fidelity of translesion synthesis
Journal Article
UV damage
WRN protein, human
Werner Syndrome Helicase
Werner syndrome protein WRN
Y family DNA polymerases

Anmerkungen:

Date Completed 19.04.2024

Date Revised 19.04.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1101/gad.351410.123

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36993119X